Glutamic-Pyruvate Transaminase (GPT), also known as Alanine Aminotransferase (ALT), is an enzyme that plays a crucial role in the metabolism of amino acids and glucose. It catalyzes the reversible transamination between L-alanine and alpha-ketoglutarate to produce L-glutamate and pyruvate . This enzyme is found in various tissues, but it is most abundant in the liver .
GPT belongs to the class-I pyridoxal-phosphate-dependent aminotransferase family and has two distinct molecular and genetic forms: one cytoplasmic (GPT1) and one mitochondrial (GPT2) . The enzyme requires the coenzyme pyridoxal phosphate for its activity . The His Tag Active form of GPT is a recombinant version that includes a histidine tag, which facilitates its purification and detection in research applications .
GPT is widely used as a biomarker for liver health. Elevated levels of GPT in the blood can indicate liver damage or disease, such as viral hepatitis, diabetes, or bile duct problems . It is commonly measured in liver function tests alongside aspartate aminotransferase (AST), and the ratio of AST to ALT is used to diagnose various liver conditions .
The recombinant form of GPT, particularly the His Tag Active version, is produced using advanced biotechnological methods. This involves the expression of the human GPT gene in a suitable host system, followed by purification using the histidine tag . The recombinant enzyme retains the functional properties of the native enzyme and is used in various research and diagnostic applications .
Recombinant GPT is used in: